checkAd
    Startseite > Aktien > argenx > Nachrichten
    argenx Aktie
    346,45
     
    EUR
    +0,54 %
    +1,85 EUR
    Letzter Kurs 16.05.24 Lang & Schwarz
    344,50
     
    EUR
    14 STK
    Geldkurs 16.05.24
    348,40
     
    EUR
    14 STK
    Briefkurs 16.05.24
    ISIN: NL0010832176 · WKN: A11602 · Niederlande

    Neueste Nachrichten

    argenx Reports First Quarter 2024 Financial Results and Provides Business Update
    09.05.24 · globenewswire · argenx
    argenx announces results of Annual General Meeting of Shareholders
    07.05.24 · globenewswire · argenx
    argenx to Present at BofA Securities 2024 Health Care Conference
    07.05.24 · globenewswire · argenx
    argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
    02.05.24 · globenewswire · argenx
    argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
    16.04.24 · globenewswire · argenx
    argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
    27.03.24 · globenewswire · argenx
    argenx Announces Annual General Meeting of Shareholders on May 7, 2024
    26.03.24 · globenewswire · argenx
    argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
    26.03.24 · globenewswire · argenx
    argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
    07.03.24 · globenewswire · argenx
    argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
    29.02.24 · globenewswire · argenx
    argenx to Present at Upcoming Investor Conferences
    26.02.24 · globenewswire · argenx
    argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024
    22.02.24 · globenewswire · argenx